4 Myeloproliferative Neoplasms Clinical Trials in Philadelphia, PA (2026)

Q: How do I join a clinical trial in Philadelphia?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you.

Recruiting Myeloproliferative Neoplasms Studies in Philadelphia

NCT06313593Recruiting

A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms

This study is being conducted to assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 in Participants With Myeloproliferative Neoplasms....

Philadelphia, PA186 participantsIncyte Corporation

View Study Details

NCT07469891Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

This is a first-in-human, open-label, multi-center Phase 1 study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of PRT12396 in participants with high-risk po...

Philadelphia, PA100 participantsPrelude Therapeutics

View Study Details

NCT05233618Recruiting

Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)

In this study, tagraxofusp (Tag) is given to patients with CD 123+ myelofibrosis (MF), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) after allogeneic stem cell transplant (H...

Philadelphia, PA44 participantsKaren Ballen, MD

View Study Details

NCT06218628Recruiting

Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

This is a prospective phase I dose-escalation study, with the primary objective to access the MTD and find the RP2D of talazoparib, given in combination with standard of care dosing of pacritinib....

Philadelphia, PA24 participantsFox Chase Cancer Center

View Study Details

About Myeloproliferative Neoplasms Clinical Trials in Philadelphia

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 4 myeloproliferative neoplasms clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 354 participants. Research is being sponsored by Incyte Corporation, Prelude Therapeutics, Karen Ballen, MD and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in Philadelphia — FAQ

Are there myeloproliferative neoplasms clinical trials in Philadelphia?

Yes, there are 4 myeloproliferative neoplasms clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 4 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated July 13, 2026 from ClinicalTrials.gov